|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Cash and cash equivalents of CIP | ||||||||||||||||||||
| Accounts receivable and other assets of CIP | ||||||||||||||||||||
| Investments of CIP | ||||||||||||||||||||
| Assets held for policyholders | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Property, equipment and software, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Investments and other assets of consolidated investment products (CIP) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Debt | ||||||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||||||
| Other liabilities of CIP | ||||||||||||||||||||
| Policyholder payables | ||||||||||||||||||||
| Debt and other liabilities of CIP | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| TEMPORARY EQUITY | ||||||||||||||||||||
| Redeemable noncontrolling interests in consolidated entities | ||||||||||||||||||||
| PERMANENT EQUITY | ||||||||||||||||||||
| Equity attributable to Invesco Ltd.: | ||||||||||||||||||||
| Preferred shares ($0.20 par value; $1,000 liquidation preference; 4.0 million authorized and issued; 2.5 million outstanding as of June 30, 2026 (December 31, 2025: 2.5 million outstanding) | ||||||||||||||||||||
| Common shares ($0.20 par value; 1,050.0 million authorized; 566.1 million shares issued as of June 30, 2026 and December 31, 2025) | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Treasury shares | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income/(loss), net of tax | ||||||||||||||||||||
| Total equity attributable to Invesco Ltd. | ||||||||||||||||||||
| Equity attributable to nonredeemable noncontrolling interests in consolidated entities | ||||||||||||||||||||
| Total permanent equity | ||||||||||||||||||||
| Total liabilities, temporary and permanent equity | ||||||||||||||||||||
Loading...
